Clinical Trial: A prospective, single-arm, pre-post observational study evaluating the impact of switching from mepolizumab to depemokimab on patient-reported outcomes, including treatment satisfaction, convenience, and quality of life, in patients with severe eosinophilic asthma (Japan)

Tokyo, April 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061347) titled 'A prospective, single-arm, before-and-after comparative study evaluating the impact of switching from mepolizumab to depemokimab on patient satisfaction, treatment convenience, and quality of life in patients with severe eosinophilic asthma' on April 22.

Study Type: Observational

Primary Sponsor: Institute - Social Medical Corporation St. Francis Society Himeji St. Mary's Hospital

Condition: Condition - severe asthma Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To prospectively evaluate the impact of switching from an IL-5 antibody (mepolizumab) to depemokimab...